Protective effect of cholecystokinin octapeptide on angiotensin II‐induced apoptosis in H9c2 cardiomyoblast cells

2019 ◽  
Vol 121 (7) ◽  
pp. 3560-3569
Author(s):  
Can Wang ◽  
Huan Yu ◽  
Limu Wei ◽  
Jingqi Zhang ◽  
Mingyang Hong ◽  
...  



PLoS ONE ◽  
2014 ◽  
Vol 9 (4) ◽  
pp. e96220 ◽  
Author(s):  
Ayyappan Prathapan ◽  
Vadavanath Prabhakaran Vineetha ◽  
Kozhiparambil Gopalan Raghu




Phytomedicine ◽  
2019 ◽  
Vol 57 ◽  
pp. 1-8 ◽  
Author(s):  
Yeh-Peng Chen ◽  
Kalaiselvi Sivalingam ◽  
Marthandam Asokan Shibu ◽  
Rajendran Peramaiyan ◽  
Cecilia Hsuan Day ◽  
...  


2014 ◽  
Vol 153 (3) ◽  
pp. 552-560 ◽  
Author(s):  
Eun-Seok Park ◽  
Jun Chul Kang ◽  
Yong Chang Jang ◽  
Jong Seok Park ◽  
Shin Yi Jang ◽  
...  


2001 ◽  
Vol 87 (4) ◽  
pp. 289-296 ◽  
Author(s):  
XinShou Ouyang ◽  
Kyoko Takahashi ◽  
Katsuko Komatsu ◽  
Norio Nakamura ◽  
Masao Hattori ◽  
...  


2003 ◽  
Vol 44 (5) ◽  
pp. 2252 ◽  
Author(s):  
Nora P. Rotstein ◽  
Luis E. Politi ◽  
O. Lorena German ◽  
Romina Girotti


2004 ◽  
Vol 286 (3) ◽  
pp. H1063-H1069 ◽  
Author(s):  
Jin-Jiang Pang ◽  
Rong-Kun Xu ◽  
Xiang-Bin Xu ◽  
Ji-Min Cao ◽  
Chao Ni ◽  
...  

Loss of cardiomyocytes by apoptosis is proposed to cause heart failure. Angiotensin II (ANG II), an important neurohormonal factor during heart failure, can induce cardiomyocyte apoptosis. Inasmuch as hexarelin has been reported to have protective effects in this process, we examined whether hexarelin can prevent cardiomyocytes from ANG II-induced cell death. Cultured cardiomyocytes from neonatal rats were stimulated with ANG II. Apoptosis was evaluated using fluorescence microscopy, TdT-mediated dUTP nick-end labeling (TUNEL) method, flow cytometry, DNA laddering, and analysis of cell viability by (3,4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). It was found that incubation with 0.1 μmol/l ANG II for 48 h increased cardiomyocyte apoptosis. Administration of 0.1 μmol/l hexarelin significantly decreased this ANG II-induced apoptosis and DNA fragmentation and increased myocyte viability. To further investigate the underlying mechanisms, caspase-3 activity assay and mRNA expression of Bax, Bcl-2, and growth hormone secretagogue receptor (GHS-R; the supposed hexarelin binding site) were examined. GHS-R mRNA was abundantly expressed in cardiomyocytes and was upregulated after administration of hexarelin. These results suggest that hexarelin abates cardiomyocytes from ANG II-induced apoptosis possibly via inhibiting the increased caspase-3 activity and Bax expression induced by ANG II and by increasing the expression of Bcl-2, which is depressed by ANG II. Whether the upregulated expression of GHS-R induced by hexarelin is associated with this antiapoptotic effect deserves further investigation.



Sign in / Sign up

Export Citation Format

Share Document